Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Innovations and highlights in the Pharma industry 

Dive deep into the world of Pharma with Zamann’s Expert Blog. Our industry-leading professionals share insights on global project management, quality consultancy, digitalization, and more. Stay updated with trends and innovations transforming the Pharma industry. 

News and more

The FDA’s proposed PDUFA VIII framework could move manufacturing readiness discussions much earlier in the drug approval process. The plan introduces new CMC facility interactions before submission, stronger communication during inspections and additional engagement after inspection findings. For pharmaceutical sponsors,
Explore current pharmaceutical consultant salary benchmarks across roles, specialties, locations, and employment models. This guide explains how experience, regulatory expertise, GMP knowledge, and contract structure shape earnings, helping life science professionals compare opportunities and plan their next consulting move.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has highlighted a Class 2 recall of one batch of Fingolimod Zentiva 0.5 mg Capsules after shelf-life testing identified a potential risk of metal-particle contamination. Zentiva UK Pharma Limited is recalling
Vitruvias Therapeutics is voluntarily recalling one nationwide lot of Thyroid Tablets, USP 30 mg after testing confirmed potential superpotency. The affected lot 504950 was distributed across the United States between January 31 and September 30, 2025. FDA published the company
Explore how the pharmaceutical supply chain connects GDP controls, cold-chain logistics, serialization, supplier oversight, and shortage prevention. Learn practical strategies to strengthen traceability, reduce distribution risks, and build more resilient, compliant pharmaceutical logistics operations across global networks today.
The FDA has placed Regenxbio’s experimental Hunter syndrome gene therapy RGX-121 on clinical hold after spinal scans identified abnormalities in five study participants. The patients received the treatment about three to six years ago and remain asymptomatic. However, the regulatory
Karnataka authorities are investigating an alleged interstate drug network after officials seized medicines, expired stock, counterfeit labels, packaging materials and an injection-filling unit worth about ₹4.91 crore from an unlicensed facility near Bidadi. The recovered stock included products labelled as
Learn how pharma project consultants support regulated projects through planning, engineering, technology transfer, qualification, validation, and GMP controls. This guide explains where project risks emerge, what strong governance requires, and how companies can achieve compliant project handover.